[Post treatment follow-up of patients with testicular cancer by primary care physicians].
Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
Raphael
R
Steiner
Klinik für Onkologie, Universitätsspital Zürich.
Jörg
J
Beyer
D000293:Adolescent; D000328:Adult; D000359:Aftercare / Q000379:methods*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D007984:Leydig Cell Tumor / Q000473:pathology / Q000628:therapy*; D008134:Long-Term Care; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000628:therapy*; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D009919:Orchiectomy; D011320:Primary Health Care; D018239:Seminoma / Q000473:pathology / Q000628:therapy; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*; D055815:Young Adult
D000970:Antineoplastic Agents; D002945:Cisplatin